InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Venker Eric, Chief Executive Officer. Officer active across 2 companies, notably Immunovant, Inc.. In total, 6 disclosures have been recorded. Total volume traded: €947k. The latest transaction was filed on 1 April 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
US$5m368,750 shares@ US$12.47570.082% mcap100.0% of flow
Common Stock
SEC:0001764013-26-000024·
€5m368,750 shares@ €12.47570.082% mcap50.0% of flow
Common Stock
SEC:0001764013-26-000024:0·
€477,132136,421 shares@ €3.49750.0023% mcap50.4% of flow
Common Shares
SEC:0000899243-22-019396:0·
€18,3045,107 shares@ €3.5840.0001% mcap1.9% of flow
Common Shares
SEC:0000899243-22-015798:0·
€83,84519,336 shares@ €4.33620.0004% mcap8.9% of flow
Common Shares
SEC:0000899243-22-013166:0·
€367,88780,045 shares@ €4.5960.0018% mcap38.8% of flow
Common Shares
SEC:0000899243-22-012702:0·
6 of 6 declarations
About Venker Eric
Eric Venker is Chief Executive Officer and President of Immunovant, Inc. and Roivant Sciences Ltd. He leads the strategic and business operations of these companies, focusing on growth and innovation in the biopharmaceutical sector. With a strong background in drug development, Eric oversees major projects and research initiatives. His leadership is essential for achieving the objectives of Immunovant and Roivant Sciences.
